HYPERLOOP Trademark

Trademark Overview

On Friday, October 6, 2023, a trademark application was filed for HYPERLOOP with the United States Patent and Trademark Office. The USPTO has given the HYPERLOOP trademark a serial number of 98212707. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, January 20, 2026. This trademark is owned by Superluminal Medicines, Inc.. The HYPERLOOP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines
hyperloop

General Information

Serial Number98212707
Word MarkHYPERLOOP
Filing DateFriday, October 6, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, January 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical preparations and medicines
Pseudo MarkHYPER LOOP

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code042
First Use Anywhere DateWednesday, February 26, 2025
First Use In Commerce DateThursday, August 14, 2025

Trademark Owner History

Party NameSuperluminal Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameSuperluminal Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2023NEW APPLICATION ENTERED
Saturday, October 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2024ASSIGNED TO EXAMINER
Monday, June 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 3, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 3, 2025SOU EXTENSION 1 FILED
Monday, March 3, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 29, 2025TEAS STATEMENT OF USE RECEIVED
Friday, August 29, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 16, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 29, 2025SOU EXTENSION 2 FILED
Saturday, January 17, 2026SOU EXTENSION 2 GRANTED
Friday, August 29, 2025USE AMENDMENT FILED
Saturday, January 17, 2026STATEMENT OF USE PROCESSING COMPLETE
Saturday, January 17, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 20, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 20, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 20, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 20, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 20, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

hyperloop medicines preparations pharmaceutical development